Chem. J. Chinese Universities ›› 2019, Vol. 40 ›› Issue (10): 2111.doi: 10.7503/cjcu20190108

• Organix Chemistry • Previous Articles     Next Articles

Synthesis and Anti-tumor Activity Evaluation of a Series of 2- or 4-Substituted Pyrido[3,2-d]pyrimidines as Nonclassical Antifolates

FANG Fang1,XUE Liangmin1,CONG Jing1,TIAN Chao1,WANG Xiaowei1,LIU Junyi1,2,ZHANG Zhili1,*()   

  1. 1. Department of Chemical Biology, School of Pharmaceutical Sciences
    2. State Key Labroatory of Natural and Biomimetic Drugs, Peking University, Beijing 100191
  • Received:2019-02-17 Online:2019-10-08 Published:2019-06-01
  • Contact: ZHANG Zhili E-mail:Lilybmu@bjmu.edu.cn
  • Supported by:
    † Supported by the National Nature Science Foundation of China(No.21172014)

Abstract:

Using compounds 2,4-diamino-6-(4-methylphenethyl)pyrido [3,2-d] pyrimidine(wm-5b) and 2,4-diaminopyrido [3,2-d] pyrimidine as the lead compounds, a series of 2- or 4-substituted pyrido[3,2-d]pyrimidines was synthesized as potential nonclassical antifolates by means of microwave efficiently. Besides, the effects of different substituted positions which provides more theoretical basis for the design and synthesis of nonclassical antifolates can be explored. The target compounds were characterized by 1H NMR, 13C NMR as well as MS. All compounds showed certain anti-tumor activity[compound 6b, the most potent one, has IC50 values of (4.09±0.48) μmol/L against HL-60 cells, IC50 value of (17.99±7.20) μmol/L against A549 cells and IC50 value of (14.52±4.74) μmol/L against HCT116 cells], while some of them exhibited certain inhibition of recombinant human DHFR(rhDHFR). Some compounds and the lead were applied to molecular docking of the crystal structure of dihydrofolate reductase, and the activity results and structure-activity relationship were explained at the molecular level.

Key words: Nonclassical antifolate, Pyrido[3,2-d]pyrimidine derivative, Antitumor activity, Inhibition of dihydrofolate reductase

CLC Number: 

TrendMD: